DSN
D. Scott Neal Portfolio holdings
AUM
$216M
1-Year Est. Return
33.28%
1 Year Est. Return
+33.28%
AUM
$201M
AUM Growth
+$20.3M
(+11%)
Holding
57
Top Buys
| 1 | +$3.97M | |
| 2 | +$465K | |
| 3 | +$459K | |
| 4 |
Broadcom
AVGO
|
+$282K |
| 5 |
Oracle
ORCL
|
+$262K |
Top Sells
| 1 | +$609K | |
| 2 | +$572K | |
| 3 | +$212K | |
| 4 |
Merck
MRK
|
+$204K |
| 5 |
Microsoft
MSFT
|
+$103K |
Sector Composition
| 1 | Financials | 23.19% |
| 2 | Technology | 16.68% |
| 3 | Real Estate | 4.09% |
| 4 | Industrials | 1.73% |
| 5 | Consumer Discretionary | 1.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Vanguard ESG US Stock ETF
ESGV
$11.8B
| $232K | 0.12% |
2,114
+49
|
|
||
52
Empire State Realty Series ES
ESBA
$2.05B
| $228K | 0.11% |
29,000
|
|
||
53
Novo Nordisk
NVO
$204B
| $222K | 0.11% |
3,210
-40
|
|
||
54
Goldman Sachs
GS
$239B
| $212K | 0.11% |
+300
|
|
||
55
LivePerson
LPSN
$52.6M
| $25.4K | 0.01% |
1,674
|
|
||
56
Costco
COST
$409B
| – | – |
-224
|
|
||
|
57
Merck
MRK
$215B
| – | – |
-2,270
|
|